Amgen (AMGN)Officer sold ~$825K
Rachna Khosla, Officer at Amgen, sold ~$825K of Amgen shares.
- ~$825K
- Approx. value · 2,000 sh @ $412.57
- 6,404
- Holds after · shares reported
- Traded
- Aug 11, 2026
- Filed
- Aug 13, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 27, 2026CongressDisclosed sale of AMGN — reported range $15,001 - $50,000
- Jun 5, 2026CongressDisclosed purchase of AMGN — reported range $1,001 - $15,000
- Jul 29, 2026Company filing · Form 8-K · Cyber incidentReported a cybersecurity incident“In July 2026, Amgen Inc. (the "Company") identified unauthorized activity involving data stored in cloud environments hosted by third-party cloud service providers.”
- Aug 4, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 6, 2026Insider · 2 peopleInsiders: 4 sales (~$2.8M)
- Aug 11, 2026 · this disclosureInsiderOfficer sold ~$825K of AMGN shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Amgen
For Amgen, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports and 75 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AMGN page.
Other recent filings by Rachna Khosla, SVP, Business Development
- SEC Form 4 at Amgen (AMGN)Aug 13, 2026
- SEC Form 4 at Amgen (AMGN)Nov 14, 2025
- SEC Form 4 at Amgen (AMGN)Jun 6, 2025
The full history of Rachna Khosla, SVP, Business Development is on the profile page.
How this filing works
Other disclosures at Amgen
- House Clerk periodic transaction reportOct 1, 2026
- House Clerk periodic transaction reportSep 5, 2026
- House Clerk periodic transaction reportSep 5, 2026
- Senate eFD periodic transaction reportSep 2, 2026
- SEC Form 13F-HRAug 26, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its AMGN page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
